AF
HAE icon

Amalgamated Financial’s Haemonetics HAE Stock Holding History

Amalgamated Financial’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.15M Buy
+33,943
New +$1.85M 0.02% 875

Other funds holding HAE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCP
LGT Capital Partners Pfaeffikon, Switzerland $1.88B AUM 20.37% 1-Year Est. Return

Amalgamated Financial's HAE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Haemonetics (HAE) in Q1 2022: 33,943 shares worth $2.15M. The stake represents 0.02% of the portfolio and ranks #875 among its holdings.

242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • Amalgamated Financial held 33,943 shares of Haemonetics worth $2.15M as of Q1 2022.
  • Haemonetics was a new Amalgamated Financial position in Q1 2022.
  • Haemonetics made up 0.02% of Amalgamated Financial's portfolio in Q1 2022, its #875 holding.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.